Clinical Trials Browser

Phase 2 × Adenocarcinoma × atezolizumab × Clear all

NCT05968326 2026-03-12

IMCODE003

Phase 2 Recruiting

Adenocarcinoma

NCT04400474 2025-06-19

CABATEN

Phase 2 Completed

93 enrolled 17 charts

CNSEndocrineHead & NeckNET

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

NCT04739202 2021-03-29

IMMUNOGAST

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms